Herbalife Ltd.

Report azionario NYSE:HLF

Capitalizzazione di mercato: US$1.3b

Herbalife Crescita futura

Criteri Future verificati 2/6

Herbalife prevede che gli utili e i ricavi cresceranno rispettivamente di 15.8% e 3.2% all'anno. Si prevede che l'EPS crescerà di 13.7% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 1731.4% in 3 anni.

Informazioni chiave

15.8%

Tasso di crescita degli utili

13.69%

Tasso di crescita dell'EPS

Personal Products crescita degli utili33.1%
Tasso di crescita dei ricavi3.2%
Rendimento futuro del capitale proprio1,731.39%
Copertura analitica

Low

Ultimo aggiornamento13 May 2026

Aggiornamenti recenti sulla crescita futura

Recent updates

Articolo di analisi • May 19

Investors Can Find Comfort In Herbalife's (NYSE:HLF) Earnings Quality

Investors were disappointed with the weak earnings posted by Herbalife Ltd. ( NYSE:HLF ). However, our analysis...
Seeking Alpha • May 11

Herbalife: The Stock Wall Street Loves To Hate Is Making A Comeback

Summary Herbalife is undergoing a significant transformation, shifting from its traditional multi-level marketing model to a modern health and wellness brand. HLF is leveraging biomarker-driven personalization, direct digital health engagement, and strategic acquisitions like Bioniq and Pro2col to diversify its offerings. Recent debt refinancing and ongoing reductions have improved HLF's financial profile, with debt falling from ~$3.0B in 2021 to ~$2.18B in 2025. Wall Street has largely discounted HLF's transformation, overlooking its established brand, cash flow, and loyal customer base supporting its strategic pivot. Read the full article on Seeking Alpha
Aggiornamento della narrazione • May 05

HLF: Mixed 2026 Guidance And Execution Outlook Will Shape Turnaround Prospects

Herbalife's analyst price target has been revised higher to $17.50 from $16.50, with analysts pointing to updated fair value assumptions and recent target increases at firms such as Citi, BofA and Mizuho following Q4 results and 2026 guidance. Analyst Commentary Recent research updates show a mix of optimism and caution around Herbalife, with price targets moving in different directions as analysts react to Q4 results, 2026 guidance and updated assumptions around execution and valuation.
Aggiornamento della narrazione • Apr 20

HLF: 2026 Guidance And Margin Recovery Will Drive Turnaround Momentum

Analysts lifted their price targets for Herbalife by as much as $4, with some pointing to Q4 results that were largely in line, fresh 2026 guidance, and what they view as stronger recent momentum as key factors behind the adjustment. Analyst Commentary Bullish analysts are highlighting recent price target increases on Herbalife as a sign of improving confidence in the story, especially after Q4 results that were described as largely in line and supported by new 2026 guidance.
Aggiornamento della narrazione • Apr 06

HLF: Turnaround Momentum And Q1 2026 Outlook Will Support Margin Recovery

Herbalife's updated analyst price target has moved from $14.00 to $16.50 as analysts factor in recent target increases, slightly higher projected revenue growth and margins, and a modestly lower discount rate, alongside updated views on valuation multiples. Analyst Commentary Recent research views on Herbalife show a mix of optimism about a potential turnaround and caution about the broader sector and the company’s fundamentals.
Aggiornamento della narrazione • Mar 23

HLF: 2026 Turnaround Ambitions Will Face Ongoing Competitive And Fundamental Pressures

Herbalife's analyst price target has shifted toward $9.00, with recent research citing Q4 results viewed as solid by some firms, new 2026 guidance, and mixed views on valuation and competitive pressures. Some analysts also commented that regulatory concerns in the U.S. are considered resolved and the business model more sustainable.
Aggiornamento della narrazione • Mar 09

HLF: 2026 Turnaround Hopes Will Confront Persistent Competitive And Fundamental Risks

The analyst price target for Herbalife has been raised by $1 to $9. Analysts point to largely in line Q4 results, new 2026 guidance, and a mix of Buy, Neutral, and Underperform views that reflect both perceived momentum and ongoing concerns around competition, fundamentals, and valuation.
Aggiornamento della narrazione • Feb 23

HLF: Turnaround Will Be Driven By 2026 Guidance And Margin Recovery

Narrative Update: Herbalife The updated analyst fair value estimate for Herbalife has moved from $11 to $25, a shift analysts link to refreshed price targets in the $9 to $21 range, stronger Q4 commentary, improved margin assumptions, and a lower discount rate despite mixed views on long term growth and valuation risks. Analyst Commentary Recent Street research on Herbalife reflects a mix of views, but several bullish analysts have been willing to raise price targets or upgrade their stance following recent updates from the company.
Aggiornamento della narrazione • Feb 08

HLF: Turnaround Hopes Under New Leadership Will Confront Compressed Sector Multiples

Narrative Update: Herbalife Analyst Price Target Move The blended analyst price target for Herbalife has moved higher, with recent increases such as Mizuho's lift to $13 and Maxim's initiation at $20. Analysts point to an ongoing turnaround, progress under new leadership, and a healthier long term profile for Herbalife's business model, while also noting continuing concerns about competition and broader macro uncertainty.
Aggiornamento della narrazione • Jan 25

HLF: Recovery Story Under New Leadership Will Face Compressed Sector Multiples

Narrative Update on Herbalife The analyst price target for Herbalife has been revised higher to reflect an updated fair value of $8.00, a lower discount rate of 10.02%, and adjustments to revenue growth, profit margin, and future P/E assumptions, as analysts factor in recent target hikes, Buy initiations, and views of a continuing recovery path under new leadership. Analyst Commentary Recent Street research on Herbalife reflects a mix of optimism about a potential recovery and caution around execution and valuation risks.
Articolo di analisi • Jan 22

Herbalife Ltd. (NYSE:HLF) Shares Fly 27% But Investors Aren't Buying For Growth

Herbalife Ltd. ( NYSE:HLF ) shares have continued their recent momentum with a 27% gain in the last month alone. The...
Aggiornamento della narrazione • Jan 11

HLF: Turnaround And Margin Recovery Under New Leadership Will Face Valuation Constraints

The analyst price target on Herbalife in our model has moved from US$12 to US$14, as analysts point to a recovery path supported by a healthier profit margin outlook, a slightly lower discount rate, and recent research highlighting ongoing business model improvements despite tempered revenue growth expectations and cautious sector valuations. Analyst Commentary Recent research on Herbalife reflects a mix of optimism about the company’s turnaround efforts and caution about broader sector and macro headwinds.
Aggiornamento della narrazione • Dec 25

HLF: Recovery Path Under New Leadership Will Likely Deliver Disappointing Multiple Expansion

Analysts have modestly raised their fair value estimate for Herbalife from approximately $9.67 to $12.00 per share, citing a lower perceived risk profile, steady growth and margin assumptions, and a more constructive view on future earnings multiples as fundamentals continue on a recovery path under new leadership. Analyst Commentary Analyst sentiment around Herbalife is gradually improving as execution under new leadership gains traction and forward growth expectations firm up, though views on the pace and durability of the recovery remain mixed.
Aggiornamento della narrazione • Dec 11

HLF: Recovery Path Under New Leadership Will Likely Prove Overpriced

Analysts have modestly raised their price target on Herbalife to $11 from $10, citing a gradually lower perceived risk profile, steady long term growth and margin assumptions, and growing confidence that the company is on a recovery path under new leadership, with a potential return to volume growth by fiscal 2026. Analyst Commentary Bullish analysts point to the recent rating upgrade and price target increase as evidence that sentiment around Herbalife is gradually improving, with expectations that operational execution will support a more favorable risk and reward profile over the next several years.
Aggiornamento della narrazione • Nov 27

HLF: Uncertainty Around CEO Transition Will Challenge Near-Term Momentum

Herbalife’s analyst price target has been raised to $11 from $10, as analysts point to recovering fundamentals and the company’s strategic leadership changes as promising signs for future growth. Analyst Commentary Analysts have recently weighed in on Herbalife, offering a mix of optimism about its improving fundamentals and some caution about ongoing risks.
Articolo di analisi • Nov 13

We Think That There Are Some Issues For Herbalife (NYSE:HLF) Beyond Its Promising Earnings

The market for Herbalife Ltd.'s ( NYSE:HLF ) stock was strong after it released a healthy earnings report last week...
Articolo di analisi • Oct 29

The Market Doesn't Like What It Sees From Herbalife Ltd.'s (NYSE:HLF) Earnings Yet

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...
Articolo di analisi • Sep 26

At US$8.75, Is Herbalife Ltd. (NYSE:HLF) Worth Looking At Closely?

Herbalife Ltd. ( NYSE:HLF ), might not be a large cap stock, but it saw a decent share price growth of 11% on the NYSE...
Articolo di analisi • Jul 24

A Look At The Intrinsic Value Of Herbalife Ltd. (NYSE:HLF)

Key Insights The projected fair value for Herbalife is US$9.20 based on 2 Stage Free Cash Flow to Equity Herbalife's...
Articolo di analisi • Jun 25

There's No Escaping Herbalife Ltd.'s (NYSE:HLF) Muted Earnings Despite A 26% Share Price Rise

Those holding Herbalife Ltd. ( NYSE:HLF ) shares would be relieved that the share price has rebounded 26% in the last...
Articolo di analisi • May 28

Herbalife (NYSE:HLF) Hasn't Managed To Accelerate Its Returns

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Articolo di analisi • May 08

Herbalife's (NYSE:HLF) Earnings Offer More Than Meets The Eye

Herbalife Ltd.'s ( NYSE:HLF ) solid earnings announcement recently didn't do much to the stock price. We did some...
Articolo di analisi • Mar 13

Herbalife Ltd.'s (NYSE:HLF) Share Price Boosted 63% But Its Business Prospects Need A Lift Too

Herbalife Ltd. ( NYSE:HLF ) shares have had a really impressive month, gaining 63% after a shaky period beforehand. But...
Seeking Alpha • Feb 24

Herbalife: The Battleground Stock Is Showing Some Turnaround Potential

Summary Herbalife still operates in 95 countries using a direct selling and MLM model with six million independent distributors. Currently, HLF is facing declining sales volumes, which have been partly offset by price increases. However, it remains uncertain how sustainable this is in the long run. Post-FTC settlement, I think HLF has “sanitized” its business model, even though it has indeed made it more challenging to grow its MLM business. The good news is its focus. They have a mixed regional performance, in particular with China struggling while Asia Pacific stabilizes. Additionally, its recruitment and sales leaders numbers have been encouraging in Q4 and 2024. Based on EV/EBITDA metrics, HLF is undeniably still priced at a steep discount. However, at this point, I believe the risk-reward equation is more favorable for the bulls. Hence, I rate it a speculative “Buy” for the short term. Read the full article on Seeking Alpha
Articolo di analisi • Feb 19

Is It Time To Consider Buying Herbalife Ltd. (NYSE:HLF)?

While Herbalife Ltd. ( NYSE:HLF ) might not have the largest market cap around , it saw a double-digit share price rise...
Articolo di analisi • Jan 29

Returns At Herbalife (NYSE:HLF) Appear To Be Weighed Down

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...
Seeking Alpha • Jan 21

Herbalife: Down In The Dumps, But Maybe Worth Exploring

Summary Herbalife (HLF) which offers health and wellness products across the globe has underperformed other small-caps and consumer staple stocks, while witnessing almost a 50% contraction in price over the past year. The new Chief Strategy Officer has helped revive new distributor growth after years of decline, but sales growth remains stagnant, and the outlook on the topline doesn't look too alluring. While the topline is not at full tilt, HLF's restructuring efforts are leading to a great deal of savings ($130m of aggregate savings through 2025) resulting in decent EBITDA growth. The stock is attractively priced at 4x EBITDA and an FCF yield of 27%. HLF is yet to show signs of bottom formation, although the risk-reward equation within its long-term descending channel looks favorable. Read the full article on Seeking Alpha
Articolo di analisi • Nov 12

Investors Still Aren't Entirely Convinced By Herbalife Ltd.'s (NYSE:HLF) Earnings Despite 27% Price Jump

Herbalife Ltd. ( NYSE:HLF ) shares have had a really impressive month, gaining 27% after a shaky period beforehand. Not...
Articolo di analisi • Nov 06

We Think You Can Look Beyond Herbalife's (NYSE:HLF) Lackluster Earnings

Herbalife Ltd.'s ( NYSE:HLF ) stock was strong despite it releasing a soft earnings report last week. However, we think...
Seeking Alpha • Nov 05

Herbalife: A Top Short Squeeze Idea, Turning Higher In Price

Summary Herbalife is trading near a 20-year low valuation in October 2024. Earnings have beaten expectations for 3 consecutive quarters and are projected to grow by 20% annually in 2025-26. A large short interest position may be stuck, meaning any covering (buying shares) will push the share price straight up. Something of a price breakout has appeared on the daily chart pattern over the past week. Read the full article on Seeking Alpha
Articolo di analisi • Nov 01

What Does Herbalife Ltd.'s (NYSE:HLF) Share Price Indicate?

Herbalife Ltd. ( NYSE:HLF ), is not the largest company out there, but it saw a decent share price growth of 12% on the...
Seeking Alpha • Oct 03

Herbalife: The Biggest Value Trap Of The Moment

Summary Herbalife's products lack scientific backing, are highly processed, and fail to improve consumer health, leading to stalled growth and brand credibility issues. The MLM business model does not convince the market, undermining the long-term trust and credibility of the brand, despite appearing undervalued based on valuation multiples. Without drastic changes in product quality and business model, Herbalife is likely to face a gradual decline, as evidenced by stagnant financial performance. Read the full article on Seeking Alpha

Previsioni di crescita degli utili e dei ricavi

NYSE:HLF - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviUtiliFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/20285,597N/AN/AN/A1
12/31/20275,426311N/A4624
12/31/20265,249246N/A4144
3/31/20265,133240374447N/A
12/31/20255,038228253333N/A
9/30/20254,962321217305N/A
6/30/20254,929325171265N/A
3/31/20254,951280164272N/A
12/31/20244,993254163285N/A
9/30/20245,00187180312N/A
6/30/20245,04282156292N/A
3/31/20245,075137188325N/A
12/31/20235,062142223358N/A
9/30/20235,028186173315N/A
6/30/20235,042226156305N/A
3/31/20235,121252123268N/A
12/31/20225,204321196353N/A
9/30/20225,342305224384N/A
6/30/20225,477340244403N/A
3/31/20225,637398321481N/A
12/31/20215,803447309460N/A
9/30/20215,896483347487N/A
6/30/20215,986504400531N/A
3/31/20215,781474476597N/A
12/31/20205,542373517629N/A
9/30/20205,351356571673N/A
6/30/20205,074299624728N/A
3/31/20204,967260457561N/A
12/31/20194,877311N/A458N/A
9/30/20194,843303N/A440N/A
6/30/20194,842293N/A418N/A
3/31/20194,887311N/A531N/A
12/31/20184,892297N/A648N/A
9/30/20184,799184N/A696N/A
6/30/20184,641168N/A659N/A
3/31/20184,503211N/A572N/A
12/31/20174,428214N/A591N/A
9/30/20174,379377N/A522N/A
6/30/20174,416410N/A276N/A
3/31/20174,471249N/A402N/A
12/31/20164,488260N/A367N/A
9/30/20164,542245N/A385N/A
6/30/20164,523251N/A638N/A
3/31/20164,483357N/A609N/A
12/31/20154,469339N/A629N/A
9/30/20154,504358N/A555N/A
6/30/20154,658276N/A523N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di HLF ( 15.8% all'anno) è superiore al tasso di risparmio ( 3.5% ).

Guadagni vs Mercato: Si prevede che gli utili di HLF ( 15.8% all'anno) cresceranno più lentamente rispetto al mercato US ( 16.8% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di HLF cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di HLF ( 3.2% all'anno) crescerà più lentamente rispetto al mercato US ( 11.7% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di HLF ( 3.2% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di HLF sarà molto alto tra 3 anni ( 1731.4 %).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/05/22 13:38
Prezzo dell'azione a fine giornata2026/05/22 00:00
Utili2026/03/31
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Herbalife Ltd. è coperta da 16 analisti. 4 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
John StaszakArgus Research Company
Meredith AdlerBarclays
Brian WangBarclays